We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MSEX:NASDAQMiddlesex Water Company Analysis

Data as of 2026-04-18 - not real-time

$51.31

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Middlesex Water Company (MSEX) is trading at $51.31, which sits below its 20‑day ($52.29), 50‑day ($52.85) and 200‑day ($53.27) simple moving averages, indicating a short‑term bearish bias. The RSI of 44.8 and a bearish MACD histogram reinforce the downside momentum, while the stock hovers just above the calculated support level of $49.86 and well under the resistance of $56.30. Volume remains stable, but the 30‑day volatility of 32.5% is unusually high for a utility, suggesting price swings may be sharper than typical peers. On the valuation side, the forward P/E of 17.0 is modestly below the industry average of 22.6, and the current P/E of 21.7 is only slightly under the sector norm, positioning the stock at a fair price relative to peers. However, the discounted cash‑flow model produces a fair value of just $9.48, a stark contrast to the market price, highlighting a potential overvaluation signal from intrinsic‑value calculations. Despite this, analysts project a target price of $60, implying roughly a 17% upside, supported by a 2.73% dividend yield, a sustainable payout ratio of 58%, and forward EPS growth from $2.36 to $3.01.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below all major moving averages
  • Bearish MACD and neutral RSI
  • Proximity to technical support level

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Analyst target price of $60 (~17% upside)
  • Forward EPS growth and modest valuation multiples
  • Attractive dividend yield with sustainable payout

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Regulated water utility provides stable cash flows
  • High debt-to-equity ratio adds balance‑sheet risk
  • Consistent dividend and low beta reduce market sensitivity

Key Metrics & Analysis

Financial Health

Revenue Growth-0.30%
Profit Margin22.00%
P/E Ratio21.7
ROE9.09%
ROA2.82%
Debt/Equity84.26
P/B Ratio1.9
Op. Cash Flow$62.6M
Free Cash Flow$-29954250
Industry P/E22.6

Technical Analysis

TrendBearish
RSI44.8
Support$49.86
Resistance$56.30
MA 20$52.29
MA 50$52.85
MA 200$53.27
MACDBearish
VolumeStable
Fear & Greed Index90.21

Valuation

Fair Value$9.48
Target Price$60.00
Upside/Downside16.94%
GradeFair
TypeBlend
Dividend Yield2.73%

Risk Assessment

Beta-0.10
Volatility32.47%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.